TEL AVIV, Israel, March 1, 2021 /PRNewswire/ -- Vascular Grafts Solutions (VGS) Ltd. announced today receipt of marketing clearance from the Food and Drug Administration (FDA) for the VIOLA™, a new ...

St Paul, MN - The FDA has granted 510(k) clearance to St Jude Medical Inc to market its sutureless aortic anastomosis device for coronary bypass graft surgery, the company has announced. Since ...

Objectives. To evaluate the efficacy of percutaneous transluminal coronary angioplasty (PTCA) for anastomotic stenosis after coronary artery bypass grafting (CABG) in patients with Kawasaki disease ...

The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) recently published several recommendations regarding OPCAB versus traditional on-pump CABG based on meta-analysis of ...

Please provide your email address to receive an email when new articles are posted on . Like other specialties in medicine, cardiology has seen an influx in interest in less invasive therapeutic ...

Beating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% cost reduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The ...